Stepping Stones: A Peer Perspective Navigating Through Pregnancy and Postpartum Experiences

References

• Broussard, C. S., Rasmussen, S. A., Reefhuis, J., et al. (2011). Maternal treatment with opioid analgesics and risk for birth defects. American Journal of Obstetrics and Gynecology, 204(3), 314.e1–11. https://doi.org/10.1016/j.ajog.2010.12.024
• Crapanzano, K., Vath, R. J., & Fisher, D. (2014). Reducing stigma towards substance users through an educational intervention: Harder than it looks. Academic Psychiatry: The Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 38(1), 1-6. https://doi.org/10.1007/s40596-013-0014-4
• Frazak, P. (2017). Report on CompCare needs assessment—interviews and focus groups (1-23).
• Kocherlakota, P. (2014). Neonatal abstinence syndrome. Pediatrics, 134(2), e547-e561. https://doi.org/10.1542/peds.2013-3524
• Logan, B. A., Brown, M. S., & Hayes, M. J. (2013). Neonatal abstinence syndrome: Treatment and pediatric outcomes. Clinical Obstetrics and Gynecology, 56(1), 186-192. https://doi.org/10.1097/GRF.0b013e31827fee84
• Medication-assisted treatment remains the recommended therapy for pregnant women. (2017). American College of Obstetricians and Gynecologists. https://www.acog.org/about-acog/news-room/news-releases/2017/medication-assisted-treatment-remains-the-recommended-therapy--for-pregnant-women
• Medline. (2015). Neonatal abstinence syndrome. https://medlineplus.gov/ency/article/007313.htm
• NIDA. (2012, July 6). Buprenorphine during pregnancy reduces neonate distress. https://www.drugabuse.gov/news-events/nida-notes/2012/07/buprenorphine-during-pregnancy-reduces-neonate-distress
• Room, R. (2005). Stigma, social inequality and alcohol and drug use. Centre for Social Research on Alcohol and Drugs, Stockholm University. Addiction, 100(3), 143-155. https://doi.org/10.1111/j.1360-0443.2004.00861.x
• SAMHSA. (2016). A collaborative approach to the treatment of pregnant women with opioid use disorders. https://ncsacw.samhsa.gov/files/collaborative_approach_508.pdf
• SAMHSA. (2018). Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. https://store.samhsa.gov/shin/content/SMA18-5054/SMA18-5054.pdf
• Smith, K., & Lipari, R. (2017). Women of childbearing age and opioids. https://www.samhsa.gov/data/sites/default/files/report_2724/shortreport-2724.html
• Wisconsin Department of Health Services. (n.d.). Women, infants, and children (WIC). https://www.fns.usda.gov/wic/women-infants-and-children-wi
• Wisconsin Department of Justice. (n.d.). Protecting Wisconsin’s pregnant, substance-addicted mothers and their unborn child. https://www.doj.state.wi.us/solicitor-general/protecting-wisconsins-pregnant-substance-addicted-mothers-and-their-unborn
• Wisconsin Department of Health Services. (n.d.). Home visitation documentation. https://www.dhs.wisconsin.gov/library/homevisitationdocumentation.htm
• Wisconsin Department of Health Services. (n.d.). Access Wisconsin. https://access.wisconsin.gov
• WAPC. (2018). Perinatal substance use and abuse: Resources. https://perinatalweb.org/major-initiatives/perinatal-substance-use-and-abuse/resource